Published • loading... • Updated
Big Food pours millions into rebrands as obesity drugs reshape US demand
U.S. food companies shift to smaller portions, simpler ingredients, and protein-rich options as 20% of households use appetite-suppressing GLP-1 drugs, PwC analysis shows.
- This year, global food and beverage companies are reformulating recipes, shortening ingredient lists and shrinking pack sizes in 2026 amid rising GLP-1 drug use.
- Adoption of GLP‑1 drugs more than doubled in 12 months to December, with about 20% of U.S. households including at least one user, and users consume 40% fewer calories on average, PwC analysis shows.
- Companies such as General Mills and Coca‑Cola are rolling out protein- and fiber-forward items, with General Mills launching higher-protein Cheerios and Coca‑Cola increasing Fairlife production last year.
- Analysts estimate EY‑Parthenon projects up to $12 billion lost in snack sales over the next decade, while capital expenditure is rising and Kraft Heinz pledged $600 million this year.
- Smaller businesses are seizing opportunities and accelerating pipelines as retail grocery baskets shrink 4% to 6% for families and up to 9% for single-person households.
Insights by Ground AI
Podcasts & Opinions
9 Articles
9 Articles
Big Food pours millions into rebrands as obesity drugs reshape U.S. demand
Global food and beverage companies from PepsiCo to Coca-Cola are focusing on shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 drugs for weight loss.
·Toronto, Canada
Read Full Article
Big Food pours millions into rebrands as obesity drugs reshape US demand
Global food and beverage companies from PepsiCo to Coca-Cola are focusing on shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 drugs for weight loss.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources9
Leaning Left1Leaning Right1Center6Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
13%
C 75%
12%
Factuality
To view factuality data please Upgrade to Premium
